Comfortology by BetterRX

What Is Transparent Hospice Medication Management?

Written by BetterRX | Nov 19, 2026, 9:03:28 PM

The Question CFOs Are Actually Asking

When a CFO or CEO asks whether a hospice's medication management is transparent, they're usually asking something more specific than it sounds: can I see what we're actually paying for a medication and its delivery, separate from whatever margin the pharmacy partner is keeping? In a lot of pharmacy relationships, the honest answer is no. The invoice shows a total. It doesn't show the split.

That gap matters more in hospice than almost anywhere else in healthcare, because the hospice organization itself bears the medication cost under the Medicare Hospice Benefit's per-diem structure, rather than passing that cost to an outside insurer. A hidden spread isn't an abstract inefficiency. It's a direct hit to the hospice's own margin, dollar for dollar.

 

Transparent vs. Spread-Based: What Actually Differs

 

Why This Matters Beyond the Finance Team

Transparent medication management isn't purely a CFO concern, even though CFOs are usually the ones pushing hardest for it. Clinical leaders benefit from the same visibility, since knowing the real cost of a medication at the point of order, alongside a lower-cost clinically appropriate alternative, lets a nurse or prescriber make a cost-aware decision without slowing down care. Operations leaders benefit because transparent pricing is easier to standardize and audit consistently across multiple locations than a spread-based model that can vary site to site.

 

How BetterRX Builds Transparency Into the Model

BetterRX uses transparent, pass-through pharmacy pricing and does not profit from medication or delivery markups. Incentives stay aligned with the hospice: better care, lower unnecessary costs, and medications reaching patients as quickly as possible. Intelligent Medication Management pairs that pricing structure with real-time cost intelligence, surfacing pricing and lower-cost alternatives at the moment of ordering rather than in a delayed report, and Actionable Reporting & Analytics gives finance and operations leaders a live view of per-patient-day (PPD) performance instead of last month's numbers.

The pharmacy side of the relationship bears this out directly. In a 2024 Qualtrics survey of more than 100 independent pharmacies, 96% said they prefer BetterRX to traditional hospice PBMs, and 94% said BetterRX speeds order fulfillment, a meaningful signal that a transparent, aligned-incentive model works well on both sides of the relationship, not just for the hospice.

That kind of outcome is what transparency is supposed to produce: not just a clearer invoice, but decisions made differently because the real cost was visible in time to act on it. It's the difference between a finance team that finds out about a cost pattern after a quarter has already closed and one that catches it while there's still time to change course.

 

What Transparency Doesn't Mean

It's worth being precise about what transparent medication management is not. It isn't a promise that medications will always be cheap, and it isn't a guarantee that every cost will trend downward every month. Medication prices genuinely fluctuate for reasons outside any pharmacy partner's control, including manufacturer pricing changes and supply disruptions. What transparency actually promises is narrower and more useful: that the hospice can see why a cost is what it is, and can trust that the number reflects a real, disclosed cost rather than an invisible markup layered on top of it.

This distinction matters because a hospice that expects transparency to mean permanently falling costs will eventually feel misled by ordinary market movement. A hospice that understands transparency as visibility, not a price ceiling, is better equipped to use that visibility for what it's actually good for: catching real cost drivers, forecasting accurately, and holding a pharmacy partner accountable to the pricing structure it agreed to.

 

Making Transparency Part of How the Organization Operates

Transparent medication management works best when it's treated as an ongoing operating standard, not a one-time contract term negotiated at signing. Reviewing real-time cost data on a regular cadence, tying it to Predictable PPD goals, and making sure every location has the same visibility keeps transparency from quietly eroding as an organization grows or adds new sites.

 

Common Mistakes to Avoid When Evaluating Transparency Claims

Hospice leaders evaluating a pharmacy partner's transparency claims run into a few predictable traps. Recognizing them ahead of time makes it easier to ask the right follow-up question instead of taking a claim at face value.